Torsdag 2 Januari | 15:10:24 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-11-07 08:00 Kvartalsrapport 2025-Q3
2025-08-08 08:00 Kvartalsrapport 2025-Q2
2025-05-22 N/A Årsstämma
2025-05-09 08:00 Kvartalsrapport 2025-Q1
2025-02-21 08:00 Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning RAY B 0.70 SEK
2024-05-23 - X-dag bonusutdelning RAY B 1.3
2024-05-22 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-11-17 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning RAY B 0.00 SEK
2023-05-25 - Årsstämma
2023-05-17 - Kvartalsrapport 2023-Q1
2023-02-28 - Bokslutskommuniké 2022
2022-11-29 - Kvartalsrapport 2022-Q3
2022-08-29 - Kvartalsrapport 2022-Q2
2022-05-27 - X-dag ordinarie utdelning RAY B 0.00 SEK
2022-05-25 - Årsstämma
2022-05-18 - Kvartalsrapport 2022-Q1
2022-02-23 - Bokslutskommuniké 2021
2021-11-18 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-27 - X-dag ordinarie utdelning RAY B 0.00 SEK
2021-05-26 - Årsstämma
2021-05-05 - Kvartalsrapport 2021-Q1
2021-02-23 - Bokslutskommuniké 2020
2020-11-18 - Kvartalsrapport 2020-Q3
2020-08-26 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning RAY B 0.00 SEK
2020-06-30 - Årsstämma
2020-05-05 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-20 - Kvartalsrapport 2019-Q2
2019-05-22 - X-dag ordinarie utdelning RAY B 0.00 SEK
2019-05-21 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-20 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-31 - X-dag ordinarie utdelning RAY B 0.00 SEK
2018-05-29 - Årsstämma
2018-05-09 - Kvartalsrapport 2018-Q1
2018-02-15 - Bokslutskommuniké 2017
2017-11-22 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-24 - X-dag ordinarie utdelning RAY B 0.00 SEK
2017-05-23 - Årsstämma
2017-05-19 - Kvartalsrapport 2017-Q1
2017-02-17 - Bokslutskommuniké 2016
2016-11-18 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-18 - X-dag ordinarie utdelning RAY B 0.25 SEK
2016-05-17 - Årsstämma
2016-05-12 - Kvartalsrapport 2016-Q1
2016-02-18 - Bokslutskommuniké 2015
2015-11-25 - Kvartalsrapport 2015-Q3
2015-08-28 - Kvartalsrapport 2015-Q2
2015-05-29 - X-dag ordinarie utdelning RAY B 0.00 SEK
2015-05-28 - Årsstämma
2015-05-08 - Kvartalsrapport 2015-Q1
2015-02-12 - Bokslutskommuniké 2014
2014-11-27 - Kvartalsrapport 2014-Q3
2014-08-27 - Kvartalsrapport 2014-Q2
2014-05-28 - X-dag ordinarie utdelning RAY B 0.00 SEK
2014-05-27 - Årsstämma
2014-05-16 - Kvartalsrapport 2014-Q1
2014-02-13 - Bokslutskommuniké 2013
2013-11-27 - Kvartalsrapport 2013-Q3
2013-08-28 - Kvartalsrapport 2013-Q2
2013-05-23 - X-dag ordinarie utdelning RAY B 0.00 SEK
2013-05-22 - Årsstämma
2013-05-16 - Kvartalsrapport 2013-Q1
2013-02-14 - Bokslutskommuniké 2012
2012-11-16 - Kvartalsrapport 2012-Q3
2012-08-28 - Kvartalsrapport 2012-Q2
2012-05-31 - X-dag ordinarie utdelning RAY B 0.00 SEK
2012-05-30 - Årsstämma
2012-05-23 - Kvartalsrapport 2012-Q1
2012-02-16 - Bokslutskommuniké 2011
2011-11-24 - Kvartalsrapport 2011-Q3
2011-05-26 - X-dag ordinarie utdelning RAY B 0.50 SEK
2011-05-25 - Årsstämma
2011-05-04 - Kvartalsrapport 2011-Q1
2011-02-18 - Bokslutskommuniké 2010
2010-11-12 - Kvartalsrapport 2010-Q3
2010-08-27 - Kvartalsrapport 2010-Q2
2010-05-26 - X-dag ordinarie utdelning RAY B 0.50 SEK
2010-05-25 - Årsstämma
2010-05-11 - Kvartalsrapport 2010-Q1
2009-11-20 - Kvartalsrapport 2009-Q3
2009-08-27 - Kvartalsrapport 2009-Q2
2009-05-27 - X-dag ordinarie utdelning RAY B 0.00 SEK
2009-05-26 - Årsstämma
2009-05-15 - Kvartalsrapport 2009-Q1
2008-06-25 - Split RAY B 1:3
2003-06-10 - Split RAY B 20:1

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
RaySearch Laboratories är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av mjukvarulösningar för sjukvårdsindustrin. Bolagets produkter används främst inom behandling av cancer och andra allvarliga sjukdomar, och vidaresäljs som dosplanerings- respektive informationssystem. Olika funktioner inkluderar maskininlärning, beräkningshastighet, automatiserad planering, virtuell simulering, adaptiv terapi och digitala arbetsflöden. Produkterna används av ett flertal kliniker.
2024-09-27 10:00:00

RaySearch will be exhibiting its latest software innovations at ASTRO in Washington, D.C., September 29 - October 1. Participants can book demonstrations (https://www.raysearchlabs.com/astro-2024/) of RayStation®* treatment planning system, RayCare®* oncology information system, and the cloud-based oncology analytics system RayIntelligence® in RaySearchs's booth #327 during the event. Additionally, joint solutions between RaySearch and its industry partners Vision RT, GE Healthcare, Leo Cancer Care, and C-RAD will be presented.

RAystation - comprehensive and automated

RayStation demonstrations will include the latest improvements, making the software even more comprehensive and automated. This includes the coming new fast automated replanning module, along with automatic image import, immediately followed by structure definition using deep learning segmentation.

To further enhance RayStation's comprehensive planning toolkit, a new SRS planning tool for the simultaneous treatment of multiple tumors is under development. Moreover, secondary acceptance levels for clinical goals and improved screen capture functionality have been introduced to ensure all necessary tools are integrated into a single planning system.

In particle therapy planning, emerging technologies such as optimization based on linear energy transfer (LET) and proton arc planning will be highlighted.

RAycare - centered around the patient journey

RayCare is designed to be centered around the patient's journey, providing a unified oncology workflow for all clinical staff involved in the patient's care throughout the course of treatment.

At ASTRO, active oncology workflows will be showcased, along with automation that enhances the entire patient's journey. A new dedicated workspace for treatment course management will be demonstrated as well. This workspace supports all user needs related to managing the fractionation schedule for treatments, including plan assignment, treatment settings management, and handling approvals.

RayCare is a machine-agnostic system, and the goal is to support all treatment delivery machines from all vendors in the oncology field. A major step towards this goal was achieved last spring with the interoperability certificate between RayCare and the TrueBeam family of linear accelerators. A few months later, the first patient was treated using RayCare together with a Varian TrueBeam® linear accelerator. Attendees will have the opportunity to learn more about it at the congress.

RAyintelligence - data-driven clinical decisions

In the latest version of the cloud-based oncology analytics system RayIntelligence, data from both RayStation and RayCare has been incorporated. This latest integration with RayCare opens an entirely new environment for data-driven decisions, facilitating day-to-day clinical duties as well as long-term process planning. Example use cases will be illustrated through customizable dashboards.

Johan Löf, founder and CEO, RaySearch, says: "We are excited to return to ASTRO in Washington, meeting valued partners as well as customers and potential customers. We are also eager to showcase our latest product innovations to attendees joining us in our booth."

About RAYSEARCH

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. 

RaySearch's software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.

About RAYSTATION

RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.

About RAYCARE

The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today's oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.

About RAYINTELLIGENCE

Data-driven oncology represents a new era in healthcare. RayIntelligence® is an innovative cloud-based oncology analytics system that gives meaning to data, empowering cancer centers to reach new levels of personalized care through insights based on clinical data.

* Subject to regulatory clearance in some markets.

For more information, please contacT:

Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)

Telephone: +46 (0) 8 510 530 00

johan.lof@raysearchlabs.com 

Learn more about us on:
LinkedIn (http://linkedin.com/company/Raysearch-laboratories)
YouTube (http://youtube.com/user/raysearchlabs)

X (http://x.com/raysearch)